Several questions remain regarding the effect of COVID-19 infection and hypercoagulation in the management of patients taking oral contraceptives, estrogen therapy, and patients who are pregnant.
Patients with sleep-disordered breathing were more likely to have impairments in free fatty acid metabolism than those without sleep-disordered breathing.
For COVID-19 patients without a previous diagnosis of diabetes, fasting blood glucose ≥7.0 mmol/L is an independent predictor of 28-day mortality.
The FDA has granted Fast Track designation to dapagliflozin (Farxiga; AstraZeneca) to reduce the risk of hospitalization for heart failure or cardiovascular (CV) death in adults following an acute myocardial infarction.
The permanent birth control device Essure is associated with higher rates of chronic lower abdominal or pelvic pain and abnormal uterine bleeding compared with tubal ligation.
Prolonged storage of embryos after vitrification is associated with a reduced likelihood of biochemical pregnancy, clinical pregnancy, and live birth.
There has been a significant surge in the use of growth hormone to improve athletic ability and combat aging despite no clear supporting evidence.
COVID-19 is associated with hyperglycemic emergencies, particularly in patients with existing type 2 diabetes and of African ethnicity.
Hand sanitizers containing methanol, or wood alcohol, present a danger to individuals as the substance can be toxic when absorbed through the skin or life-threatening if ingested.
The majority of individuals using an online COVID-19 self-assessment tool report mild or moderate symptoms possibly associated with COVID-19.
